These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Alloreactivity and association of human natural killer cells with the major histocompatibility complex. Mavoungou E; Sall A; Poaty-Mavoungou V; Toure FS; Yaba P; Delicat A; Lansoud-Soukate J Clin Diagn Lab Immunol; 1999 Mar; 6(2):254-9. PubMed ID: 10066663 [TBL] [Abstract][Full Text] [Related]
25. Common variable immunodeficiency is associated with polymorphic markers in the human major histocompatibility complex. Howe HS; So AK; Farrant J; Webster AD Clin Exp Immunol; 1991 Mar; 83(3):387-90. PubMed ID: 1672269 [TBL] [Abstract][Full Text] [Related]
26. High-producer allele of tumour necrosis factor-alpha is part of the susceptibility MHC haplotype in severe puumala virus-induced nephropathia epidemica. Kanerva M; Vaheri A; Mustonen J; Partanen J Scand J Infect Dis; 1998; 30(5):532-4. PubMed ID: 10066063 [TBL] [Abstract][Full Text] [Related]
27. Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. Jongeneel CV; Briant L; Udalova IA; Sevin A; Nedospasov SA; Cambon-Thomsen A Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9717-21. PubMed ID: 1946393 [TBL] [Abstract][Full Text] [Related]
28. Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Mitchell SA; Grove J; Spurkland A; Boberg KM; Fleming KA; Day CP; Schrumpf E; Chapman RW; Gut; 2001 Aug; 49(2):288-94. PubMed ID: 11454808 [TBL] [Abstract][Full Text] [Related]
29. Genomic MHC haplotyping of mutant cell lines using a novel marker. Degli-Esposti MA; Williamson JF; Tay GK; Salmon B; Joseph GA; Morley AA; Dawkins RL Eur J Immunogenet; 1993 Oct; 20(5):373-80. PubMed ID: 9098405 [TBL] [Abstract][Full Text] [Related]
30. The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk. Tóth EK; Kocsis J; Madaras B; Bíró A; Pocsai Z; Fust G; Blaskó B; Karádi I; Adány R; Laki J Int J Cancer; 2007 Oct; 121(8):1744-8. PubMed ID: 17594690 [TBL] [Abstract][Full Text] [Related]
31. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Jacob CO; McDevitt HO Nature; 1988 Jan; 331(6154):356-8. PubMed ID: 2893286 [TBL] [Abstract][Full Text] [Related]
32. Conserved extended haplotypes of the major histocompatibility complex: further characterization. Dorak MT; Shao W; Machulla HK; Lobashevsky ES; Tang J; Park MH; Kaslow RA Genes Immun; 2006 Sep; 7(6):450-67. PubMed ID: 16791278 [TBL] [Abstract][Full Text] [Related]
33. Mapping of a candidate region for susceptibility to inclusion body myositis in the human major histocompatibility complex. Kok CC; Croager EJ; Witt CS; Kiers L; Mastaglia FL; Abraham LJ; Garlepp MJ Immunogenetics; 1999 Jun; 49(6):508-16. PubMed ID: 10380695 [TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor alpha gene polymorphisms and haplotypes in Egyptian children with nephrotic syndrome. Youssef DM; El-Shal AS; Hussein S; Salah K; Ahmed AERE Cytokine; 2018 Feb; 102():76-82. PubMed ID: 28803697 [TBL] [Abstract][Full Text] [Related]
35. Complex haplotypic structure of the central MHC region flanking TNF in a West African population. Ackerman HC; Ribas G; Jallow M; Mott R; Neville M; Sisay-Joof F; Pinder M; Campbell RD; Kwiatkowski DP Genes Immun; 2003 Oct; 4(7):476-86. PubMed ID: 14551600 [TBL] [Abstract][Full Text] [Related]
36. Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3. Price P; Santoso L; Mastaglia F; Garlepp M; Kok CC; Allcock R; Laing N Tissue Antigens; 2004 Nov; 64(5):575-80. PubMed ID: 15496200 [TBL] [Abstract][Full Text] [Related]
37. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism. Mäkelä S; Mustonen J; Ala-Houhala I; Hurme M; Partanen J; Vapalahti O; Vaheri A; Pasternack A J Infect Dis; 2002 Sep; 186(6):843-6. PubMed ID: 12198621 [TBL] [Abstract][Full Text] [Related]
38. MHC class III polymorphisms in selection of donors for BMT. Dorak MT; Chalmers EA; Sproul AM; Mills KI; Wilson DW; Galbraith I; Henderson N; Gibson BE; Burnett AK Bone Marrow Transplant; 1993 Jan; 11(1):37-41. PubMed ID: 8094307 [TBL] [Abstract][Full Text] [Related]
39. Polymorphic analysis of the three MHC-linked HSP70 genes. Milner CM; Campbell RD Immunogenetics; 1992; 36(6):357-62. PubMed ID: 1356099 [TBL] [Abstract][Full Text] [Related]